The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis
Abstract
BACKGROUND: There is increasing recognition of antibody-mediated immunotherapy-responsive neurologic diseases and a need for appropriate immunoassays. OBJECTIVES: To develop a clinically applicable quantitative assay to detect the presence of aquaporin-4 (AQP4) antibodies in patients with neuromyelitis optica and to characterize the anti-AQP4 antibodies. DESIGN: We compared a simple new quantitative fluorescence immunoprecipitation assay (FIPA) with both indirect immunofluorescence and an AQP4-transfected cell-based assay, both previously described. We used the cell-based assay to characterize the antibodies for their immunoglobulin class, IgG subclass, and ability to induce complement C3b deposition in vitro. SETTING: United Kingdom and Germany. PARTICIPANTS: Serum samples from patients with neuromyelitis optica (n = 25) or longitudinally extensive transverse myelitis (n = 11) and from relevant controls (n = 78) were studied. MAIN OUTCOME MEASURES: Comparison of different assays for AQP4 antibodies and characterization of anti-AQP4 antibodies in patients with neuromyelitis optica. RESULTS: We found antibodies to AQP4 in 19 of 25 patients with neuromyelitis optica (76%) using FIPA, in 20 of 25 patients with neuromyelitis optica (80%) using the cell-based assay, and in 6 of 11 patients with longitudinally extensive transverse myelitis (55%) with both assays; these assays were more sensitive than indirect immunofluorescence and 100% specific. The antibodies bound to extracellular epitope(s) of AQP4, were predominantly IgG1, and strongly induced C3b deposition. CONCLUSIONS: Aquaporin-4 is a major antigen in neuromyelitis optica, and antibodies can be detected in more than 75% of patients. Further studies on larger samples will show whether this novel FIPA is suitable for clinical use. The IgG1 antibodies bind to AQP4 on the cell surface and can initiate complement deposition. These approaches will be useful for investigation of other antibody-mediated diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239 · cited 2×
“0 ( 1-8) 4:7 6 (3-19) MS (n=38) 10:28 40.”
Czeizel, A. E., & Dudás, I. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272602 · Cited by 3,178
Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
A vision for the future of genomics research
Collins, F. S., Green, E. D., Guttmacher, A. E., Guyer, M. S., & on behalf of the US National Human Genome Research Institute (2003) · Nature · doi:10.1038/nature01626 · Cited by 1,752
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Morrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716
The Teratogenicity of Anticonvulsant Drugs
Holmes, L. B., Harvey, E. A., Coull, B. A., Huntington, K. B., Khoshbin, S., Hayes, A. M., & Ryan, L. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441504 · Cited by 655
An open label study of the effects of rituximab in neuromyelitis optica
Cree, B. A. C., Lamb, S., Morgan, K., Chen, A., Waubant, E., & Genain, C. (2005) · Neurology · doi:10.1212/01.wnl.0000159399.81861.d5 · Cited by 646
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 614
Plasma exchange for severe attacks of CNS demyelination: Predictors of response
Keegan, M., Pineda, A. A., McClelland, R. L., Darby, C. H., Rodriguez, M., & Weinshenker, B. G. (2002) · Neurology · doi:10.1212/wnl.58.1.143 · Cited by 600
The longer term outcome of children born to mothers with epilepsy
Adab, N. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029132 · Cited by 580
Birthweight by gestational age in Norway
SKJÆRVEN, R., GJESSING, H. K., & BAKKETEIG, L. S. (2000) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079006440.x · Cited by 552
Sherman, S. L., Allen, E. G., Bean, L. H., & Freeman, S. B. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20157 · Cited by 529
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 494
Spina Bifida in Infants of Women Treated with Carbamazepine during Pregnancy
Rosa, F. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241006 · Cited by 452
Perinatal outcome and later implications of intrauterine growth restriction
Pallotto, E. K., & Kilbride, H. W. (2006) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-200606000-00008 · Cited by 427
Increased rate of major malformations in offspring exposed to valproate during pregnancy
Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., & Holmes, L. B. (2005) · Neurology · doi:10.1212/01.wnl.0000154516.43630.c5 · Cited by 390
Mandler, R. N., Ahmed, W., & Dencoff, J. E. (1998) · Neurology · doi:10.1212/wnl.51.4.1219 · Cited by 366
Lamotrigine and the risk of malformations in pregnancy
Hauser, W. A., & Tomson, T. (2006) · Neurology · doi:10.1212/01.wnl.0000203710.88804.29 · Cited by 314
Antiepileptic drug use of women with epilepsy and congenital malformations in offspring
Artama, M., Auvinen, A., Raudaskoski, T., Isojärvi, I., & Isojärvi, J. (2005) · Neurology · doi:10.1212/01.wnl.0000163771.96962.1f · Cited by 305
In utero antiepileptic drug exposure: Fetal death and malformations
Meador, K. J., Baker, G. A., Finnell, R. H., Kalayjian, L. A., Liporace, J. D., Loring, D. W., Mawer, G., Pennell, P. B., Smith, J. C., & Wolff, M. C. (2006) · Neurology · doi:10.1212/01.wnl.0000227919.81208.b2 · Cited by 277
Wide, K., Winbladh, B., & Källén, B. (2004) · Acta Paediatrica · doi:10.1111/j.1651-2227.2004.tb00701.x · Cited by 264
Learning, Cognitive, and Attentional Problems in Adolescents Born Small for Gestational Age
O’Keeffe, M. J., O’Callaghan, M., Williams, G. M., Najman, J. M., & Bor, W. (2003) · Pediatrics · doi:10.1542/peds.112.2.301 · Cited by 252
Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy
Holmes, L. B., Baldwin, E. J., Smith, C. R., Habecker, E., Glassman, L., Wong, S. L., & Wyszynski, D. F. (2008) · Neurology · doi:10.1212/01.wnl.0000304343.45104.d6 · Cited by 249
Botto, L. D., Lisi, A., Robert-Gnansia, E., Erickson, J. D., Vollset, S. E., Mastroiacovo, P., Botting, B., Cocchi, G., de Vigan, C., de Walle, H., et al. (2005) · BMJ · doi:10.1136/bmj.38336.664352.82 · Cited by 246
Maternal age effect: The enigma of Down syndrome and other trisomic conditions
Gaulden, M. E. (1992) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(92)90033-6 · Cited by 239
Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
Paul, F., Jarius, S., Aktas, O., Bluthner, M., Bauer, O., Appelhans, H., Franciotta, D., Bergamaschi, R., Littleton, E., Palace, J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040133 · Cited by 208
Self-citationImmunosuppressive therapy is more effective than interferon in neuromyelitis optica
Papeix, C., Vidal, J.-S., Seze, J. D., Pierrot-Deseilligny, C., Tourbah, A., Stankoff, B., Lebrun, C., Moreau, T., Vermersch, P., Fontaine, B., et al. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070732 · Cited by 204
NMO-IgG in the diagnosis of neuromyelitis optica
Jarius, S., Franciotta, D., Bergamaschi, R., Wright, H., Littleton, E., Palace, J., Hohlfeld, R., & Vincent, A. (2007) · Neurology · doi:10.1212/01.wnl.0000256822.01222.bd · Cited by 181
Self-citationBirth defects after prenatal exposure to antiepileptic drugs
Perucca, E. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70224-6 · Cited by 180
Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?
Dolk, H., Jentink, J., Loane, M., Morris, J., & de Jong–van den Berg, L. T. W. (2008) · Neurology · doi:10.1212/01.wnl.0000316194.98475.d8 · Cited by 173
Viinikainen, K., Heinonen, S., Eriksson, K., & Kälviäinen, R. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00386.x · Cited by 170
Nilsen, R. M., Vollset, S. E., Gjessing, H. K., Magnus, P., Meltzer, H. M., Haugen, M., & Ueland, P. M. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.5.1134 · Cited by 153
Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care
Hoff, J. M., Daltveit, A. K., & Gilhus, N. E. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01538.x · Cited by 148
Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry
Vajda, F. J. E., Hitchcock, A. A., Graham, J. E., Solinas, C., O'Brien, T. J., Lander, C. M., & Eadie, M. J. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01359.x · Cited by 141
Joint association of Apgar scores and early neonatal symptoms with minor disabilities at school age
Moster, D. (2002) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.86.1.f16 · Cited by 136
Epilepsy and pregnancy: lamotrigine as main drug used
Sabers, A., Dam, M., Rogvi-Hansen, B. Á., Boas, J., Sidenius, P., Friis, M. L., Alving, J., Dahl, M., Ankerhus, J., & Dam, A. M. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00200.x · Cited by 133
The Course and Outcome of Pregnancy in Women with Epilepsy
Bjerkedal, T., & Bahna, S. L. (1973) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347309158321 · Cited by 131
Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate
Kaaja, E., Kaaja, R., Matila, R., & Hiilesmaa, V. K. (2002) · Neurology · doi:10.1212/wnl.58.4.549 · Cited by 125
Obstetric outcome in women with epilepsy
Hiilesmaa, V. K., Bardy, A. H., & Teramo, K. A. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90615-5 · Cited by 123
Autoimmune channelopathies and related neurological disorders.
Vincent, A., Lang, B., & Kleopa, K. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.024 · Cited by 118
Self-citationAntepartum Fetal Intracranial Hemorrhage, Predisposing Factors and Prenatal Sonography: A Review
Sherer, D. M., Anyaegbunam, A. M., & Onyeije, C. I. (1998) · American Journal of Perinatology · doi:10.1055/s-2007-993971 · Cited by 116
Maternal valproate dosage and foetal malformations
Vajda, F. J. E., & Eadie, M. J. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00458.x · Cited by 110
Outcome Measurement in Clinical Genetics Services: A Systematic Review of Validated Measures
Payne, K., Nicholls, S. G., McAllister, M., MacLeod, R., Donnai, D., & Davies, L. M. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00259.x · Cited by 99
Pregnancy in women who have epilepsy
Pennell, P. B. (2004) · Neurologic Clinics · doi:10.1016/j.ncl.2004.07.004 · Cited by 74
Jelliffe‐Pawlowski, L. L., & Hansen, R. L. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211111 · Cited by 55
Pregnancy, delivery, and neonatal complications after treatment with antiepileptic drugs
Pilo, C., Wide, K., & Winbladh, B. (2006) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340600604625 · Cited by 49
[Medical birth registry--an essential resource in perinatal medical research].
Irgens, L. M. (2002) · PubMed · Cited by 44
Validity of a rheumatic disease diagnosis in the Medical Birth Registry of Norway
Skomsvoll, J. F., Østensen, M., Baste, V., & Irgens, L. M. (2002) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810905.x · Cited by 42
The Fetus That Is Small for Gestational Age
Vrachnis, N., Botsis, D. S., & Iliodromiti, Z. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.028 · Cited by 40
Fetal growth in the offspring of epileptic women: results of an Italian multicentric cohort study
Mastroiacovo, P., Bertollini, R., Licata, D., & Italian Multicentric Registry of Birth Defects, E. S. G. (1988) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1988.tb03630.x · Cited by 38
Optimizing treatment of epilepsy during pregnancy
Kälviäinen, R. K., & Tomson, T. (2006) · Neurology · doi:10.1212/wnl.67.12_suppl_4.s59 · Cited by 25
Folate status in women of childbearing age with epilepsy
Kampman, M. T. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.04.003 · Cited by 18
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Cited by
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
“…was analysed using antibodies to NR1 (Millipore, USA), NR2B (kind gift from Prof F Anne Stephenson, School of Pharmacy, University of London) and PSD95 (Neuromab, USA), and analysis of EGFP fluorescence in fractions following sedimentation on a continuous sucrose gradient (Waters et al., 2008).”
InfluentialSelf-citationJarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., Kleiter, I., Kleinschnitz, C., Berthele, A., Brettschneider, J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-14 · Cited by 764
Self-citationNeuromyelitis Optica Study Group (NEMOS), Trebst, C., Jarius, S., Berthele, A., Paul, F., Schippling, S., Wildemann, B., Borisow, N., Kleiter, I., Aktas, O., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7169-7 · Cited by 595
Self-citationNeuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 563
Morvan syndrome: Clinical and serological observations in 29 cases
Irani, S. R., Pettingill, P., Kleopa, K. A., Schiza, N., Waters, P., Mazia, C., Zuliani, L., Watanabe, O., Lang, B., Buckley, C., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23577 · Cited by 540
Self-citation
Metadata
- Authors
- Waters, P., Jarius, S., Littleton, E., Leite, M. I., Jacob, S., Gray, B., Geraldes, R., Vale, T., Jacob, A., Palace, J., Maxwell, S., Beeson, D., & Vincent, A.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2008-07-01
- Volume
- 65
- Issue
- 7
- Pages
- 913-9
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2147528615
- Cited by
- 294
- References
- 60
- FWCI
- 22.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.